Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients
AUTOR(ES)
Teixeira, Raquel Lima de Figueiredo, Morato, Renata Gomes, Cabello, Pedro Hernan, Muniz, Ligia Mayumi Kitada, Moreira, Adriana da Silva Rezende, Kritski, Afrânio Lineu, Mello, Fernanda Carvalho Queiroz, Suffys, Philip Noel, Miranda, Antonio Basilio de, Santos, Adalberto Rezende
FONTE
Mem. Inst. Oswaldo Cruz
DATA DE PUBLICAÇÃO
2011-09
RESUMO
Isoniazid (INH), one of the most important drugs used in antituberculosis (anti-TB) treatment, is also the major drug involved in hepatotoxicity. Differences in INH-induced toxicity have been attributed to genetic variability at several loci, such as NAT2, CYP2E1, GSTM1 and GSTT1, that code for drug-metabolising enzymes. Our goal was to examine the polymorphisms in these enzymes as susceptibility factors to anti-TB drug-induced hepatitis in Brazilian individuals. In a case-control design, 167 unrelated active tuberculosis patients from the University Hospital of the Federal University of Rio de Janeiro, Brazil, were enrolled in this study. Patients with a history of anti-TB drug-induced acute hepatitis (cases with an increase to 3 times the upper limit of normal serum transaminases and symptoms of hepatitis) and patients with no evidence of anti-TB hepatic side effects (controls) were genotyped for NAT2, CYP2E1, GSTM1 and GSTT1 polymorphisms. Slow acetylators had a higher incidence of hepatitis than intermediate/rapid acetylators [22% (18/82) vs. 9.8% (6/61), odds ratio (OR), 2.86, 95% confidence interval (CI), 1.06-7.68, p = 0.04). Logistic regression showed that slow acetylation status was the only independent risk factor (OR 3.59, 95% CI, 2.53-4.64, p = 0.02) for the occurrence of anti-TB drug-induced hepatitis during anti-TB treatment with INH-containing schemes in Brazilian individuals.
Documentos Relacionados
- Polymorphisms in CYP2E1, GSTM1 and GSTT1 and anti-tuberculosis drug-induced hepatotoxicity
- OCCURRENCE IN RODENTS OF REVERSIBLE DRUG-INDUCED OPACITIES OF THE LENS*
- Influência da variabilidade genética humana dos genes NAT2, CYP2E1, GSTM1 e GSTT1 na ocorrência de reações adversas hepáticas induzidas pela isoniazida em pacientes com tuberculose ativa
- Drug-Induced Headache
- Drug-induced nephrotoxicity